Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 643

1.

In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.

Cottagiri M, Nyandjo M, Stephens M, Mantilla J, Saito H, Mackay IR, Rose NR, Njoku DB.

Cell Mol Immunol. 2018 Jul 20. doi: 10.1038/s41423-018-0087-y. [Epub ahead of print]

PMID:
30030493
2.

Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis.

Lleo A, Jepsen P, Morenghi E, Carbone M, Moroni L, Battezzati PM, Podda M, Mackay IR, Gershwin ME, Invernizzi P.

Sci Rep. 2016 May 19;6:25906. doi: 10.1038/srep25906.

3.

Topical anaesthetic effects on skin vasculature with potential implications for laser treatment.

Tollan CJ, MacLaren W, Mackay IR.

Lasers Med Sci. 2016 May;31(4):611-7. doi: 10.1007/s10103-016-1872-4. Epub 2016 Feb 9.

PMID:
26861976
4.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):e57-9. doi: 10.1016/j.clinre.2015.08.001. No abstract available.

5.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Dig Liver Dis. 2015 Nov;47(11):924-6. doi: 10.1016/j.dld.2015.08.007. Epub 2015 Sep 26. No abstract available.

6.

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Am J Gastroenterol. 2015 Nov;110(11):1536-8. doi: 10.1038/ajg.2015.312. Epub 2015 Sep 29. No abstract available.

7.

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Clin Gastroenterol Hepatol. 2015 Nov;13(11):1867-9. doi: 10.1016/j.cgh.2015.08.025. Epub 2015 Sep 18. No abstract available.

PMID:
26386643
8.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

J Hepatol. 2015 Nov;63(5):1285-7. doi: 10.1016/j.jhep.2015.06.031. Epub 2015 Sep 15. Review. No abstract available.

9.

Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Gastroenterology. 2015 Nov;149(6):1627-9. doi: 10.1053/j.gastro.2015.08.031. Epub 2015 Sep 15. No abstract available.

PMID:
26385706
10.

Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Gut. 2015 Nov;64(11):1671-2. doi: 10.1136/gutjnl-2015-310593. Epub 2015 Sep 14. No abstract available.

PMID:
26374822
11.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Hepatology. 2015 Nov;62(5):1620-2. doi: 10.1002/hep.28140. Epub 2015 Sep 15. No abstract available.

PMID:
26372460
12.

Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis.

Li Y, Wang W, Tang L, He X, Yan X, Zhang X, Zhu Y, Sun J, Shi Y, Ma X, Mackay IR, Gershwin ME, Han Y, Hou J.

Hepatology. 2015 Jun;61(6):1998-2007. doi: 10.1002/hep.27725. Epub 2015 Mar 18.

13.

Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis.

Zhang J, Zhang W, Leung PS, Bowlus CL, Dhaliwal S, Coppel RL, Ansari AA, Yang GX, Wang J, Kenny TP, He XS, Mackay IR, Gershwin ME.

Hepatology. 2014 Nov;60(5):1708-16. doi: 10.1002/hep.27313. Epub 2014 Sep 29.

14.

Gut reactions--from celiac affection to autoimmune model.

Anderson WH, Mackay IR.

N Engl J Med. 2014 Jul 3;371(1):6-7. doi: 10.1056/NEJMp1405192. No abstract available.

PMID:
24988553
15.

Cofactor-dependent conformational heterogeneity of GAD65 and its role in autoimmunity and neurotransmitter homeostasis.

Kass I, Hoke DE, Costa MG, Reboul CF, Porebski BT, Cowieson NP, Leh H, Pennacchietti E, McCoey J, Kleifeld O, Borri Voltattorni C, Langley D, Roome B, Mackay IR, Christ D, Perahia D, Buckle M, Paiardini A, De Biase D, Buckle AM.

Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):E2524-9. doi: 10.1073/pnas.1403182111. Epub 2014 Jun 9.

16.

The use of real-time digital video in the assessment of post-operative outcomes of breast reconstruction.

Gilmour A, Mackay IR, Young D, Hill ME, Brown L, Malyon AD.

J Plast Reconstr Aesthet Surg. 2014 Oct;67(10):1357-63. doi: 10.1016/j.bjps.2014.05.036. Epub 2014 Jun 2.

PMID:
24923524
17.

Effects of perforator number and location on the total pedicle flow and perfusion of zone IV skin and fat of DIEP flaps.

Douglas HE, Wilkinson MJ, Mackay IR.

J Plast Reconstr Aesthet Surg. 2014 Feb;67(2):212-8. doi: 10.1016/j.bjps.2013.10.048. Epub 2013 Nov 8.

PMID:
24332500
18.

Fashioning the immunological self: the biological individuality of F. Macfarlane Burnet.

Anderson W, Mackay IR.

J Hist Biol. 2014 Spring;47(1):147-75. doi: 10.1007/s10739-013-9352-1.

PMID:
23341117
19.

Autoimmune hepatitis: what must be said.

Mackay IR.

Exp Mol Pathol. 2012 Dec;93(3):350-3. doi: 10.1016/j.yexmp.2012.11.001. Epub 2012 Nov 19. Review.

PMID:
23174606
20.

Bilateral deep inferior epigastric perforator flaps based on unilateral perforators.

Gilmour A, Mackay IR.

J Plast Reconstr Aesthet Surg. 2013 Jun;66(6):848-50. doi: 10.1016/j.bjps.2012.09.016. Epub 2012 Sep 30.

PMID:
23031630
21.

BAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.

Fairfax K, Mackay IR, Mackay F.

IUBMB Life. 2012 Jul;64(7):595-602. doi: 10.1002/iub.1046. Epub 2012 May 29. Review.

22.

Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent.

Yang CY, Leung PS, Yang GX, Kenny TP, Zhang W, Coppel R, Norman GL, Ansari AA, Mackay IR, Worman HJ, Gershwin ME.

Clin Exp Immunol. 2012 Jun;168(3):261-7. doi: 10.1111/j.1365-2249.2012.04577.x.

23.

Determining reactive hyperaemia time in deep inferior epigastric perforators after temporary occlusion to allow the intraoperative comparison of vascular territories.

Tollan CJ, Maclaren WM, Mackay IR.

J Plast Reconstr Aesthet Surg. 2012 Jun;65(6):e161-2. doi: 10.1016/j.bjps.2012.01.011. Epub 2012 Mar 14. No abstract available.

PMID:
22421542
24.

Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.

Ali F, Rowley M, Jayakrishnan B, Teuber S, Gershwin ME, Mackay IR.

J Autoimmun. 2011 Sep;37(2):79-87. doi: 10.1016/j.jaut.2011.05.005. Epub 2011 Jun 16. Review.

PMID:
21680149
25.

Inflammatory bowel disease: beyond the boundaries of the bowel.

Actis GC, Rosina F, Mackay IR.

Expert Rev Gastroenterol Hepatol. 2011 Jun;5(3):401-10. doi: 10.1586/egh.11.23. Review.

PMID:
21651357
26.

The Scottish-Finnish-Swedish PARTNER study of taprostene versus placebo treatment in patients with critical limb ischemia.

Belch JJ, Ray S, Rajput-Ray M, Engeset J, Fagrell B, Lepäntalo M, McKay A, Mackay IR, Ostergren J, Ruckley CV, Salenius J.

Int Angiol. 2011 Apr;30(2):150-5.

PMID:
21427652
27.

Microvascular surgical training models.

Douglas HE, Mackay IR.

J Plast Reconstr Aesthet Surg. 2011 Aug;64(8):e210-2. doi: 10.1016/j.bjps.2010.12.024. Epub 2011 Jan 28. No abstract available.

PMID:
21277267
28.

A 50-year experience with autoimmune hepatitis: and where are we now?

Mackay IR.

J Gastroenterol. 2011 Jan;46 Suppl 1:17-28. doi: 10.1007/s00535-010-0325-2. Epub 2010 Nov 12.

PMID:
21072544
29.

The autoimmunity of primary biliary cirrhosis and the clonal selection theory.

Selmi C, Mackay IR, Gershwin ME.

Immunol Cell Biol. 2011 Jan;89(1):70-80. doi: 10.1038/icb.2010.126. Epub 2010 Oct 26. Review.

30.

Autoantibody heritability in thyroiditis: IgG subclass contributions.

Outschoorn IM, Talor MV, Hoffman WH, Rowley MJ, Mackay IR, Rose NR, Burek CL.

Autoimmunity. 2011 May;44(3):195-200. doi: 10.3109/08916934.2010.515275. Epub 2010 Oct 1.

PMID:
20883146
31.

The odd couple: a fresh look at autoimmunity and immunodeficiency.

Mackay IR, Leskovsek NV, Rose NR.

J Autoimmun. 2010 Nov;35(3):199-205. doi: 10.1016/j.jaut.2010.06.008. Epub 2010 Sep 6.

PMID:
20817405
32.

What's in a name? Experimental encephalomyelitis: 'allergic' or 'autoimmune'.

Mackay IR, Anderson WH.

J Neuroimmunol. 2010 Jun;223(1-2):1-4. doi: 10.1016/j.jneuroim.2010.03.017. Epub 2010 Apr 27.

PMID:
20427093
33.

CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosis.

Shimoda S, Harada K, Niiro H, Taketomi A, Maehara Y, Tsuneyama K, Kikuchi K, Nakanuma Y, Mackay IR, Gershwin ME, Akashi K.

Hepatology. 2010 Feb;51(2):567-75. doi: 10.1002/hep.23318.

34.

Travels and travails of autoimmunity: a historical journey from discovery to rediscovery.

Mackay IR.

Autoimmun Rev. 2010 Mar;9(5):A251-8. doi: 10.1016/j.autrev.2009.10.007. Epub 2009 Oct 31. Review.

PMID:
19883799
35.

B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.

Moritoki Y, Lian ZX, Lindor K, Tuscano J, Tsuneyama K, Zhang W, Ueno Y, Dunn R, Kehry M, Coppel RL, Mackay IR, Gershwin ME.

Hepatology. 2009 Dec;50(6):1893-903. doi: 10.1002/hep.23238. Erratum in: Hepatology. 2010 Jan;51(1):358.

36.

Clustering and commonalities among autoimmune diseases.

Mackay IR.

J Autoimmun. 2009 Nov-Dec;33(3-4):170-7. doi: 10.1016/j.jaut.2009.09.006. Epub 2009 Oct 17. Review.

PMID:
19837564
37.

Structural determinants of GAD antigenicity.

Arafat Y, Fenalti G, Whisstock JC, Mackay IR, Garcia de la Banda M, Rowley MJ, Buckle AM.

Mol Immunol. 2009 Dec;47(2-3):493-505. doi: 10.1016/j.molimm.2009.08.022. Epub 2009 Sep 23.

PMID:
19783309
38.

Sexual dimorphism in autoimmune disease.

McCombe PA, Greer JM, Mackay IR.

Curr Mol Med. 2009 Dec;9(9):1058-79. Review.

PMID:
19747114
39.

Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.

Yoshida K, Yang GX, Zhang W, Tsuda M, Tsuneyama K, Moritoki Y, Ansari AA, Okazaki K, Lian ZX, Coppel RL, Mackay IR, Gershwin ME.

Hepatology. 2009 Nov;50(5):1494-500. doi: 10.1002/hep.23132.

40.

Apotopes and the biliary specificity of primary biliary cirrhosis.

Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, Gores GJ, Ansari AA, Van de Water J, Gershwin ME.

Hepatology. 2009 Mar;49(3):871-9. doi: 10.1002/hep.22736.

41.

B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis.

Moritoki Y, Zhang W, Tsuneyama K, Yoshida K, Wakabayashi K, Yang GX, Bowlus C, Ridgway WM, Ueno Y, Ansari AA, Coppel RL, Mackay IR, Flavell RA, Gershwin ME, Lian ZX.

Gastroenterology. 2009 Mar;136(3):1037-47. doi: 10.1053/j.gastro.2008.11.035. Epub 2008 Nov 19.

PMID:
19118554
42.

Induction of autoimmune cholangitis in non-obese diabetic (NOD).1101 mice following a chemical xenobiotic immunization.

Wakabayashi K, Yoshida K, Leung PS, Moritoki Y, Yang GX, Tsuneyama K, Lian ZX, Hibi T, Ansari AA, Wicker LS, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME.

Clin Exp Immunol. 2009 Mar;155(3):577-86. doi: 10.1111/j.1365-2249.2008.03837.x. Epub 2008 Dec 15.

43.

Chronic complications and mortality in community-based patients with latent autoimmune diabetes in adults: the Fremantle Diabetes Study.

Myhill P, Davis WA, Bruce DG, Mackay IR, Zimmet P, Davis TM.

Diabet Med. 2008 Oct;25(10):1245-50. doi: 10.1111/j.1464-5491.2008.02562.x.

PMID:
19046207
44.

An actin-myosin functional assay for analysis of smooth muscle (anti-microfilament) autoantibodies in human plasma.

Martinez-Neira R, dos Remedios CG, Mackay IR.

J Immunol Methods. 2008 Sep 30;338(1-2):63-6. doi: 10.1016/j.jim.2008.07.011. Epub 2008 Aug 6.

PMID:
18691595
45.

A direct comparison of pulsed dye, alexandrite, KTP and Nd:YAG lasers and IPL in patients with previously treated capillary malformations.

McGill DJ, MacLaren W, Mackay IR.

Lasers Surg Med. 2008 Aug;40(6):390-8. doi: 10.1002/lsm.20638.

PMID:
18649379
46.

CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosis.

Shimoda S, Miyakawa H, Nakamura M, Ishibashi H, Kikuchi K, Kita H, Niiro H, Arinobu Y, Ono N, Mackay IR, Gershwin ME, Akashi K.

J Autoimmun. 2008 Sep;31(2):110-5. doi: 10.1016/j.jaut.2008.05.003. Epub 2008 Jul 21.

PMID:
18644699
47.

Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease.

Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ, Lam KS, Yoshida K, Yang GX, Hibi T, Ansari AA, Ridgway WM, Coppel RL, Mackay IR, Gershwin ME.

Hepatology. 2008 Aug;48(2):531-40. doi: 10.1002/hep.22390.

48.

Autoimmune liver serology: current diagnostic and clinical challenges.

Bogdanos DP, Invernizzi P, Mackay IR, Vergani D.

World J Gastroenterol. 2008 Jun 7;14(21):3374-87. Review.

49.

Etiopathogenesis of primary biliary cirrhosis.

Lleo A, Invernizzi P, Mackay IR, Prince H, Zhong RQ, Gershwin ME.

World J Gastroenterol. 2008 Jun 7;14(21):3328-37. Review.

50.

Historical reflections on autoimmune hepatitis.

Mackay IR.

World J Gastroenterol. 2008 Jun 7;14(21):3292-300. Review.

Supplemental Content

Loading ...
Support Center